ABCL575

· AbCellera Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABCL575, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants [Phase 1]